Provided by Tiger Trade Technology Pte. Ltd.

HANSOH PHARMA

39.620
-0.540-1.34%
Volume:5.33M
Turnover:212.79M
Market Cap:239.90B
PE:37.14
High:40.420
Open:39.880
Low:39.460
Close:40.160
52wk High:44.220
52wk Low:21.163
Shares:6.06B
HK Float Shares:6.06B
Volume Ratio:0.80
T/O Rate:0.09%
Dividend:0.44
Dividend Rate:1.12%
EPS(LYR):1.067
ROE:17.35%
ROA:9.44%
PB:5.91
PE(LYR):37.14
PS:13.91

Loading ...

Hansoh Pharmaceutical's Lung Cancer Drug Gets Breakthrough Therapy Designation in China

MT Newswires Live
·
Yesterday

HANSOH PHARMA Receives NMPA Breakthrough Therapy Designation for HS-20093-Adebrelimab Combo in Advanced NSCLC

Bulletin Express
·
Yesterday

HANSOH PHARMA's Self-Developed B7-H3-Targeting ADC HS-20093 in Combination with Adebelimumab Granted Breakthrough Therapy Designation by NMPA

Stock News
·
Yesterday

BRIEF-Hansoh Pharmaceutical Says NMPA Grants Breakthrough-Therapy Designation To Hs-20093 With Adebrelimab

Reuters
·
Yesterday

Hansoh Pharmaceutical - Nmpa Grants Breakthrough-Therapy Designation to Hs-20093 With Adebrelimab

THOMSON REUTERS
·
Yesterday

Hansoh Pharmaceutical Group Stock Advances 1.9% in Hong Kong

Dow Jones
·
Yesterday

A Look At Hansoh Pharmaceutical Group’s Valuation As XINYUE Gains Third Rare Disease Approval In China

Simply Wall St.
·
Yesterday

Hansoh Pharmaceutical Group Stock Rallies 2.6% in Hong Kong

Dow Jones
·
Apr 15

GSK sees blockbuster potential in targeted cancer therapy after promising early data

Reuters
·
Apr 12

Hansoh Pharmaceutical R&D Spend Should Boost Earnings Sustainability -- Market Talk

Dow Jones
·
Apr 06

Assessing Hansoh Pharmaceutical Group (SEHK:3692) Valuation After Earnings Growth And New XINYUE Indication Approval

Simply Wall St.
·
Apr 04

CMB International Reaffirms "Buy" Rating for HANSOH PHARMA, Raises Target Price to HK$46.41

Stock News
·
Apr 04

Hansoh Pharma says China approves Xinyue for generalized myasthenia gravis indication

Reuters
·
Apr 03

Haitong International Maintains "Outperform" Rating on HANSOH PHARMA with HK$45.94 Target Price

Stock News
·
Apr 03

Hansoh Pharmaceutical's Drug Launches Strengthen Long-Term Outlook -- Market Talk

Dow Jones
·
Apr 03

Hansoh Pharma Keeps Share Count Stable in March; Convertible Bonds Allow for Up to 81.55 Million New Shares

Bulletin Express
·
Apr 02

Hansoh Pharmaceutical Group Stock Rises 5.5% in Hong Kong

Dow Jones
·
Apr 01

CLSA Maintains "Outperform" Rating on Hansoh Pharma, Trims Target Price to HK$40

Stock News
·
Mar 31

BUZZ-Hansoh jumps most in 19 months on annual profit beat, Citi lifts target price

Reuters
·
Mar 31

Stock Track | HANSOH PHARMA Soars 7.32% in Intraday Trading Following Strong Annual Results

Stock Track
·
Mar 31